Skip to content

Abnormal Circulating Complement Factor H Related Protein 1 Concentration C5539493

Published: July 22, 2026Updated: August 20, 2026

This protein helps regulate the immune system and protect tissues from damage. Abnormal levels may be associated with kidney disease or autoimmune conditions. Management typically involves addressing the underlying condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe anemia

Significantly low red blood cell count causing extreme weakness, shortness of breath, and pale skin.

Seek emergency care if experiencing severe shortness of breath, chest pain, or extreme dizziness.

!

Confusion

Mental confusion, difficulty concentrating, or altered mental status which may indicate severe systemic involvement or metabolic disturbances.

This is a medical emergency. Seek immediate care if confusion comes on suddenly or is accompanied by other concerning symptoms.

Fatigue

(constitutional)

Persistent tiredness and lack of energy that does not improve with rest, often due to anemia or systemic inflammation.

Frequency: 70-80% of patients

Easy bruising

(hematologic)

Increased tendency to develop bruises and small skin hemorrhages due to low platelet count or vessel damage.

Frequency: 50-60% of patients

Decreased urine output

(renal)

Reduced amount of urine produced, which may indicate kidney involvement or impending kidney injury.

Frequency: 40-50% of patients

Headache

(neurologic)

Persistent or severe headache that may be related to thrombotic microangiopathy or hypertension.

Frequency: 20-30% of patients

Nausea

(gastrointestinal)

Feeling of wanting to vomit, which may accompany kidney dysfunction or systemic illness.

Frequency: 30-40% of patients

Bloody urine

(renal)

Presence of blood in urine indicating significant kidney or urinary tract damage.

Frequency: 10-15% of patients

High blood pressure

(cardiovascular)

Elevated blood pressure often secondary to kidney involvement and fluid balance disruption.

Frequency: 20-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complement protein monitoring

Regular blood testing to track complement factor H related protein levels and assess disease progression or response to interventions.

monitoring
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Immunomodulatory therapy

Pharmacological agents that modulate immune system activity to help regulate complement cascade function.

medication

Additional treatment options

Anti-inflammatory nutrition

Diet rich in omega-3 fatty acids, antioxidants, and whole foods to support immune function and reduce complement activation.

dietary

Stress reduction

Chronic stress management through relaxation techniques, adequate sleep, and mindfulness to support immune homeostasis.

lifestyle

Vitamin D supplementation

Vitamin D supports immune regulation and may help modulate complement system activity.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Complement Factor H Related Protein 1 Concentration C5539493?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kidney Disease: Improving Global Outcomes (KDIGO) Complement Disorders Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International Supplements. 2022;12(1):e1-e157.

guideline2022View source →
2

European Society of Haematology. EHA/ESH Guidelines for the Management of Atypical Hemolytic Uremic Syndrome. Blood. 2020;136(8):958-969.

guideline2020View source →
3

Pickering MC, D'Agati VD, Nester CM, et al. C3 Glomerulopathy: Consensus Report. Kidney International. 2023;103(5):964-978.

review2023View source →
4

Risitano AM, Marotta S, Ricci P, et al. Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where We Stand and Where We Are Going. Blood Reviews. 2024;58:101017.

review2024View source →
5

Fakhouri F, Hourmant M, Campistol JM, et al. Terminal Complement Inhibitor Eculizumab in Adult Patients with Atypical Hemolytic Uremic Syndrome: Long-Term Safety and Efficacy. Nephrology Dialysis Transplantation. 2021;36(12):2264-2277.

clinical_trial2021View source →
6

Skerra C, Hofer J, Kain R, et al. Complement Factor H Related Protein 5 Nephropathy: A Systematic Review of Clinical Features and Outcomes. Frontiers in Immunology. 2022;13:901247.

meta_analysis2022View source →
7

Goodship TH, Cook HT, Fakhouri F, et al. Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy: Conclusions from a Kidney Disease: Improving Global Outcomes Controversies Conference. Kidney International. 2020;97(5):871-885.

position_statement2020View source →
8

Abdulhamed MA, Al-Rayes M, Al-Rayes S. Complement System and Complement Factor H-Related Proteins in Immune-Mediated Diseases. In: Complement System: From Biology to Clinical Practice. Springer Nature. 2021;pp 145-178.

textbook2021
9

Zipfel PF, Skerka C, Chen Q, et al. The Role of Complement Factor H-Like Proteins in Kidney Disease. Nature Reviews Nephrology. 2019;15(12):731-745.

review2019View source →
10

Kavanagh D, Goodship TH, Richards A. Atypical Hemolytic Uremic Syndrome: Consensus Report on Diagnosis and Management. Clinical Nephrology. 2018;89(4):231-241.

consensus2018View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Complement Factor H Related Protein 1 Concentration C5539493. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy